AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates
Portfolio Pulse from
AtriCure (ATRC) reported a Q4 loss of $0.08 per share, which was better than the Zacks Consensus Estimate of a $0.15 loss. However, the company lagged in revenue estimates.
February 12, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AtriCure reported a Q4 loss of $0.08 per share, better than expected, but missed revenue estimates. This mixed result may lead to short-term stock volatility.
AtriCure's better-than-expected EPS loss of $0.08 compared to the estimated $0.15 is a positive sign, but missing revenue estimates could offset this. Investors may react to the mixed results, causing short-term volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100